John Celebi, President and CEO at Sensei Biotherapeutics, Inc. (SNSE), bought 500 shares at $0.85 ($425) on 2023-09-11, disclosed to the SEC on 2023-09-13.
Open-market purchase of $425 SNSE by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.